Home › Funds › Boxer Capital Management, LLC › TNGX
Boxer Capital Management, LLC position in TNGX
TANGO THERAPEUTICS INC · Health Care
Boxer Capital Management, LLC reported holding 10,876,219 shares of TNGX (TANGO THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$340.0M, representing 25.61% of its reported portfolio and ranking #1 among its reported holdings. Boxer Capital Management, LLC has disclosed TNGX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Boxer Capital Management, LLC's TNGX position evolved
Boxer Capital Management, LLC first disclosed a stake in TNGX in Q4 2024 at 10,380,999 shares (US$32.1M). The position peaked in Q2 2026 at 10,876,219 shares, worth US$340.0M. Across 7 filings, Boxer Capital Management, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 10,876,219 shares valued at US$340.0M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 10.38M | $32.08M | New |
| Q1 2025 | 10.38M | $14.22M | Hold |
| Q2 2025 | 9.77M | $50.03M | Reduce |
| Q3 2025 | 9.77M | $82.08M | Hold |
| Q4 2025 | 10.88M | $96.36M | Add |
| Q1 2026 | 10.88M | $227.53M | Hold |
| Q2 2026 | 10.88M | $339.99M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About TNGX and 13F data
TNGX (TANGO THERAPEUTICS INC) is a Health Care company. 85 other funds we track also report a position in TNGX — the largest reported positions include RTW INVESTMENTS, LP (US$434.5M), Farallon Capital Management (US$383.8M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$383.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding TNGX
- RTW INVESTMENTS, LP 13.90M sh · $434.53M · Q2 2026
- Farallon Capital Management 12.28M sh · $383.78M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 12.28M sh · $383.78M · Q2 2026
- TCG Crossover Management, LLC 9.08M sh · $283.88M · Q2 2026
- Paradigm Biocapital Advisors LP 6.36M sh · $198.74M · Q2 2026
- Siren, L.L.C. 6.18M sh · $193.17M · Q2 2026
- Deep Track Capital, LP 4.20M sh · $131.29M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 4.19M sh · $131.00M · Q2 2026
- Woodline Partners LP 4.00M sh · $125.06M · Q2 2026
- TRV GP IV, LLC 6.37M sh · $120.18M · Q2 2026
- PERCEPTIVE ADVISORS LLC 3.38M sh · $105.57M · Q2 2026
- Seven Fleet Capital Management LP 3.23M sh · $95.66M · Q2 2026
More on Boxer Capital Management, LLC
FAQ
How long has Boxer Capital Management, LLC held TNGX?
Boxer Capital Management, LLC has disclosed TNGX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is Boxer Capital Management, LLC's current position in TNGX?
As of Q2 2026, Boxer Capital Management, LLC holds 10.88M shares of TNGX (TANGO THERAPEUTICS INC), valued at $339.99M, representing 25.61% of its reported portfolio and ranking #1.
Has Boxer Capital Management, LLC been buying or selling TNGX?
In the latest 13F filing (Q2 2026), Boxer Capital Management, LLC held unchanged its position in TNGX. The position peaked in Q2 2026 at 10.88M shares.
Which other funds hold TNGX?
Other major institutional holders of TNGX include RTW INVESTMENTS, LP, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 85 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.